The prevalence and costs of the obesity epidemic and obesity-related conditions, including diabetes mellitus, is consistently increasing worldwide. Bariatric medicine is attempting to address this with weight loss and exercise programmes, and with increasing frequency, various forms of bariatric surgery. There has been considerable success reported after bariatric surgery but not without complications (Billakanty et al, 2008; Loh et al, 2013; Rubinshtein et al, 2001) . We describe 14 patients with orthostatic intolerance (OI) post bariatric surgery. We report on OI (postural dizziness, palpitations and fainting), the results of cardiovascular autonomic testing and the associated and/or causative findings as well as reviewing the literature to consider the possible mechanisms.
Introduction
Obesity is the fifth leading risk for death worldwide and is a predisposing factor for common related disorders, such as diabetes, hypertension, stroke, cancer and osteoarthritis (Wang et al, 2011) . The healthcare footprint of these obesity related diseases indicate that the lifetime medical cost of treating an obese individual is 30% more than that of an individual of normal weight. It is estimated that obesity or obesity-related treatment accounts for up to 2.8% of a country's total healthcare expenditure (Withrow et al, 2011) . Bariatric surgery is considered to be one of the most effective methods to treat obesity, particularly morbid obesity. Its use in the treatment of Type 2 diabetes has been proposed, as it may be more cost effective than other treatments (Keidar, 2011) .There are a number of procedures that can be used to adapt the gastrointestinal tract to reduce its volume and/or absorptive capacity (Khwaja et al, 2010) . The procedure chosen for each surgery is patient specific with consideration of age, body-mass index (BMI), co-morbidities and previous medical history, amongst other aspects. The benefit of these procedures has been welldocumented and include the reduction of diabetic drugs (Schauer et al, 2012) and even improvement of autonomic function (Maser et al, 2007) . After bariatric surgery patients are more productive, take less sick-leave, and utilise fewer healthcare resources. The long-term savings of bariatric surgery are estimated to offset the initial costs of the procedure in 2 to 4 years (Cremieux et al, 2008) . These outcomes are beneficial to the patients' quality of life (QoL) (Sjostrom et al, 2007) , as well as to the health service.
Documented side-effects, generally surgical in nature, present fairly soon post-operatively and are treated rapidly (Khwaja et al, 2010) . As bariatric surgery gains popularity in the treatment of obesity, complications continue to emerge. We report on a series of such patients studied in our units who were referred because of orthostatic intolerance (OI) that may have had an autonomic aetiology.
Subjects and Methods

Patients:
We evaluated the records of 14 patients referred over a 5 year period for exclusion of an underlying autonomic condition causing or contributing to OI after bariatric surgery (see Table 1 ). These symptoms included dizziness, palpitations and fainting (syncope) when upright. Some had additional symptoms affecting other systems, including gastrointestinal (GI) disturbances such as abdominal bloating, abdominal pain and diarrhoea. Table 2 ). 57.1% (8) patients had features of joint hypermobility/laxity (JHS), 62.5% (5) of these with a confirmed diagnosis of Ehlers-Danlos III (EDS III) (see Table 2 ). There is a strong association, recently recognised, between JHS/EDS III and the postural tachycardia syndrome (PoTS) (Mathias et al, 2012) . Autonomic investigations were conducted to assess cardiovascular function to exclude possible autonomic disease or dysfunction. All tests were performed using protocols established in our centres .  An atropine test was performed only in patients who had autonomic mediated syncope (AMS), with both a vasodepressor and cardio-inhibitory component, to separate the two components.
Results
Autonomic Function Testing
These tests were performed on all 14 patients. Responses to pressor tests (see methods section) were present in all. None of the results indicated cardiovascular autonomic failure. A syncopal event was provoked in 7.1% (1) patients during AFT with a HR fall of <40b/m necessitating an Atropine test (see below). 35.7 % (5) of the patients had a HR increase with orthostasis meeting the criteria for the PoTS. 50% (7) had low levels of BP (<110mmHg) during this test.
Plasma Catecholamines 42.9 %( 6) patients had blood samples taken whilst supine and during orthostasis. The plasma catecholamine levels were all within the normal range of our laboratory (normal range for noradrenaline: 200-500 pg/ml; adrenaline: 20-150 pg/ml; dopamine: 10-80 pg/ml).
Prolonged Tilt Test
This test was performed on 50% (7) 
Atropine Test
The antimuscarinic agent, atropine, was used to increase HR during HUT to determine if a provoked syncopal event was predominantly vasodepressor or cardio inhibitory in nature.
The test was performed on 2 patients who experienced syncopal episodes on tilt, during which HR fell lower than 40b/m in addition to a fall in BP. In each patient the syncopal episodes were characteristic of the vasodepressor form of autonomic mediated syncope (AMS), and there was therefore no case for consideration of a cardiac demand pacemaker. 
Discussion:
In this study, we have retrospectively reviewed the causes and autonomic investigations for OI in patients referred because of apparent OI that occurred post-bariatric surgery, and to exclude an autonomic disorder. The symptom onset varied from immediately post-operative to 3 years post-surgery.
Detailed autonomic function testing for causes of intermittent or irreversible autonomic failure (AF) indicated that there was no evidence for impairment of the sympathetic vasoconstrictor function or cardiac parasympathetic function, thus excluding AF. 57.1% (6) of the cohort had low supine levels of BP (systolic readings of<110mmHg) during testing.
42.9% (6) of patients reported pre-syncopal symptoms and 14.3% (2) We have reviewed previous publications, mainly case reports, on OI and Autonomic dysfunction after bariatric surgery, and these are referred to below. (3) had a dysautonomic response and 20% (3) had tachycardia and a PoTS response. In their study, Isoproterenol was infused, a drug known to induce syncope even in those without a history of syncope, and whether this contributed to tachycardia, independently of the underlying pathophysiological processes remains unclear. Of note is that prior to tilt testing, 3
patients had pacemakers fitted (with no benefit), 12 had been evaluated by a neurologist (without autonomic testing), 9 by an endocrinologist, and 5 by an ENT specialist, emphasising the problems when an autonomic cause is initially not considered. This study concluded that further investigation was necessary to determine the true incidence of OI following bariatric surgery, to identify patients at greater risk for developing OI following this surgery and to improve understanding of the underlying pathophysiology.
Recently, Loh et al described a patient with persistent bradycardia post-surgery (~40b/m) who had a neurocardiogenic form of syncope on tilt table testing. The description indicates that at the beginning of tilt, the HR rose to 120-130b/m, despite a resting HR of 40b/m and consistent with a diagnosis of PoTS. Consequently a pacemaker was fitted with apparent resolution of symptoms. The length of follow up with this patient was not described. As in previous studies, autonomic function testing was not carried out.
Due to the strong association between JHS/EDS III and PoTS (Mathias et al, 2012; Fikree et al,2013) , it should be important to consider this electively in anticipation of possible sideeffects of surgery. JHS/EDS III can be clinically determined readily (Fikree et al, 2013) and is of especially importance in those undergoing surgery as this connective tissue disorder is associated with GI dysfunction (Fikree et al, 2013) and also influences response to anaesthesia, to analgesics post-operatively and to recovery/wound healing time (Fikree et al, 2013 ).
This retrospective study has limitations as referrals were made by healthcare practitioners who were aware of our autonomic interests and considered autonomic dysfunction as a possibility. There are likely, as from the literature analysed, to be many more patients with OI in whom an autonomic aetiology is not considered. The size of the cohort is small, drug regimens and procedures performed varied between patients and also the time of evaluation from surgery. It would have been ideal to have tested autonomic function pre surgery.
We have speculated on some of the mechanisms, including gut peptides that may contribute to OI after bariatric surgery.
Weight loss itself may be the factor in some, especially if substantial. The largest proportion of weight appears to be lost 6 to 24 months post-surgery (Brolin et al, 1994; Behbehrani et al, 2014) .The physiological changes from reducing BMI from severely obese to normal may be comparable to those with anorexia, in whom autonomic impairment, affecting sympathetic function, has been well documented (Cong et al, 2004) . There is increasing evidence that leptin not only triggers satiety but may be involved in autonomic regulation (Paolisso et al, 2000) . Leptin may have vasodilator effects (Lembo et al, 2000) . As the stomach size is reduced in these patients, the release of leptin to signal satiety could be triggered earlier. A recent study (Lee et al, 2015) looking at the prevalence of hypoglycaemic symptoms in patients after bariatric surgery found that autonomic symptoms were more prevalent than neuroglycopenic symptoms. However, some symptoms of hypoglycaemia overlap autonomic symptoms and hypoglycaemia may, in fact, bring on autonomic symptoms. It is unclear from this questionnaire study if patients reporting these symptoms had clinically confirmed hypoglycaemia and/or had experienced hypoglycaemic and autonomic symptoms independent of each other. They also concluded though that the prevalence of these symptoms are under-reported.
There thus are several mechanisms by which the intricate homeostasis of energy balance and autonomic regulation may be disturbed post-bariatric surgery. We believe that increasing use and success of bariatric surgery for obesity provides a compelling need to investigate and elicit the mechanism of the disturbance of the OI, be they autonomic, hormonal or a combination, so it can be remedied.
Conclusions:
With rising global obesity rates and increasing use of bariatric surgery, our series, along with other reports, indicate that autonomic dysfunction causing OI occurs after bariatric surgery.
These findings, in particular with the 2008 series, indicate that OI is likely to be underreported, even if recognised. A retrospective survey in bariatric centres is needed to determine the prevalence of OI after bariatric surgery. This should be in concert with a prospective study, ideally including a pre-operative assessment to exclude initial OI, with a focus on key factors, associated disorders and if possible mechanisms that may predispose or contribute to OI after bariatric intervention.
